Prevention of rheumatic diseases: strategies, caveats, and future directions
|Published in||Rheumatic Diseases Clinics of North America. 2014, vol. 40, no. 4, p. 771-785|
|Abstract||Rheumatic diseases affect a significant portion of the population and lead to increased health care costs, disability, and premature mortality; effective preventive measures for these diseases could lead to substantial improvements in public health. Natural history studies show that for most rheumatic diseases there is a period of preclinical disease development during which abnormal biomarkers or other processes can be detected. These changes are useful to understand mechanisms of disease pathogenesis; in addition, they may be applied to estimate a personal risk of future disease while individuals are still relatively asymptomatic and ultimately be used to identify individuals who may be targeted for preventive interventions.|
This document has no fulltext available yet, but you can contact its author by using the form below.
|Research group||Mécanisme de l'inflammation articulaire (44)|
|FINCKH, Axel, DEANE, Kevin D. Prevention of rheumatic diseases: strategies, caveats, and future directions. In: Rheumatic Diseases Clinics of North America, 2014, vol. 40, n° 4, p. 771-785. https://archive-ouverte.unige.ch/unige:54922|